FDA Inspection 1165379 — Juno Therapeutics Inc
The FDA completed an inspection of Juno Therapeutics Inc on March 18, 2022 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 18, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Seattle, WA (United States)